Skip to content
Emergency:0761 1301-2200
Language: EnglishEN
Evangelisches Diakoniekrankenhaus Freiburg
Emergency
Evangelisches Diakoniekrankenhaus Freiburg
Central Emergency Department24/7 · Life-threatening: 112
Switchboard 0761 1301-01

Centres

Studies

Studies

As part of the Continence and Pelvic Floor Centre South Baden, we conduct studies, about which we would like to inform you here.

CASPO study

The CASPO study is a prospective, multicentre, single-arm cohort study. with the following aims:

  • evaluation of treatment success and
  • review of the safety of the ultra-lightweight mesh Calistar S for the transvaginal treatment of pelvic floor prolapse.

Who can take part in the study?

  • Participants with symptomatic anterior prolapse with or without involvement of the apical vaginal wall according to POP-Q score ≥ 2 (corresponds to Aa, Ba ≥ -1 and, if applicable, C ≥ -1/2 TVL)
  • Participants with recurrent prolapse

Study duration: 60 months

Status: Recruitment completed (new participation not possible)

Further information: Eudamed no.: CIV-18-12-026588, Procedure for using Calistar S

Your contacts

  • Prof. Dr. Dirk Watermann

    Chief Physician of Obstetrics & Gynaecology, Medical Director

  • Dr. Monika Gerber

    Senior Physician

  • Petra Wihler

    Study Nurse

Last updated:

Finder

Frequently searched